LifePoint forms alliance with Australian partner:
This article was originally published in Clinica
LifePoint, the Ontario, California developer of drug and alcohol testing systems, has signed an agreement with Sydney- and Brisbane-based Pacific Data Systems (PDS) for the distribution of its Impact test system in Australia. The three principal markets for the drug screening device - law enforcement, industrial workplace and medical emergency room - present an opportunity worth over US$1.6bn in total, says LifePoint.
You may also be interested in...
W3ll People is expected to add a relatively modest $7m to e.l.f. Beauty’s fiscal 2021 top line, but the brand has “major white space” opportunities, including at Target, e.l.f.’s longest-standing customer. Further, its plant-based product line includes 40 “EWG Verified” products, reflecting expertise e.l.f. is eager to tap.
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.